Hormone Research in Paediatrics
Evidence-Based Medicine
What Decision Analysis Can Offer the Clinical Decision MakerWhy Outcome Databases Such as KIGS and KIMS Are Vital Sources for Decision Analysis Applied Social Sciences, The Open University, Milton Keynes, UK
|
|
Log in to MyKarger to check if you already have access to this content.
KAB
Buy a Karger Article Bundle (KAB) and profit from a discount!
If you would like to redeem your KAB credit, please log in.
Save over 20% compared to the individual article price.
Article / Publication Details
Published online: November 17, 2004
Issue release date: June 1999
Number of Print Pages: 10
Number of Figures: 3
Number of Tables: 2
ISSN: 1663-2818 (Print)
eISSN: 1663-2826 (Online)
For additional information: https://www.karger.com/HRP
Abstract
Cognitive Continuum Theory can be used to explain why the relationship between research and practice is more problematic than is customarily assumed. The various possible sources of evidence for clinical decision making and the alternative approaches to such decision making can be located within the main modes of this continuum, each of which embodies a different balance of intuition and analysis. Decision analysis is the only technique that provides the analytical depth necessary to arrive at a decision that systematically identifies, structures and integrates all the relevant evidence on clinical parameters and patient preferences, within whatever mode that evidence is generated. The inappropriateness of using research criteria in action evaluations is pointed out. In order to illustrate the application of the Cognitive Continuum Theory and decision analysis to growth hormone (GH) therapy, and to stimulate discussion of this area, a primitive clinical decision analysis and prototype ‘clinical guidance tree’ for GH is presented here.
Related Articles:
References
-
Eddy DM: Clinical Decision Making: From Theory to Practice. Sudbury, MA, Jones and Bartlett, 1996.
-
Dowie J: The ‘pathology’ of decision making in clinical practice and a framework for evaluations; in Selbmann HK (ed.): Guidelines in Health Care. Baden-Baden, Nomos-Verlagsgesellschaft, 1998, pp 27–41.
-
Wennberg J, Gittelson A: Small area variations in health care delivery. Science 1973;183:1102–1108.
- Blumenthal D: The variation phenomenon in 1994. N Engl J Med 1994;331:1017–1018.
-
Poses RM, Wigton RM, Cebul RD, Centor RM, Collins M, Fleischli GJ: Practice variation in the management of pharyngitis: The importance of variability in patients’ clinical characteristics and in physicians’ responses to them. Med Dec Making 1993;13:293–301.
- Antman E, Lau J, Kupelnick B, Mosteller F, Chalmers T: A comparison of results of meta-analyses of randomized controlled trials and recommendations of clinical experts: Treatments for myocardial infarction. JAMA 1992;268:240–248.
-
Sackett DL, Richardson WS, Rosenberg W, Haynes RB: Evidence-Based Medicine: How to Practice and Teach EBM. Edinburgh, Churchill Livingstone, 1997.
-
Hamm R: Clinical intuition and clinical analysis: Expertise and the cognitive continuum; in: Dowie J, Elstein A (eds): Professional Judgement: A Reader in Clinical Decision Making. Cambridge, Cambridge University Press, 1988, pp 78–105.
- Dowie J: The research-practice gap and the role of decision analysis in closing it. Health Care Anal 1996;4:5–18.
-
Hammond KR: Human Judgement and Social Policy: Irreducible Uncertainty, Inevitable Error, Unavoidable Injustice. New York, Oxford University Press, 1996.
-
Dreyfus HL, Dreyfus SE: Mind over Machine: The Power of Human Intuition and Expertise in the Era of the Computer. New York, The Free Press, 1986.
-
Hammond KR: Teaching the new biology: potential contributions from research in cognition; in Friedman CP, Purcell EF (eds): The New Biology and Medical Education: Merging the Biological, Information, and Cognitive Sciences. New York, Josiah Macy Jr Foundation, 1983, pp 53–64.
-
Hammond KR, Hamm RM: Thoughts on the acquisition and application of medical knowledge; in Friedman CP, Purcell EF (eds): The New Biology and Medical Education: Merging the Biological, Information, and Cognitive Sciences. New York, Josiah Macy Jr Foundation, 1983, pp 190–197.
- Nathan DG: Clinical research: Perceptions, realities and proposed solutions. JAMA 1998;280:1427–1431.
- Dowie J: ‘Evidence-based’, ‘cost-effective’ and ‘preference-driven’ medicine: Decision analysis based medical decision making is the pre-requisite. J Health Services Res Policy 1996;1:104–113.
-
Ranke MB, Lindberg A, Guilbaud O: Prediction of growth in response to treatment with growth hormone; in Ranke MB, Gunnarsson R (eds): Progress in Growth Hormone Therapy – 5 Years of KIGS. Mannheim, J&J Verlag, 1994, pp 97–111.
-
Dowie J: Decision analysis in guideline development and clinical practice: the ‘clinical guidance tree’; in Selbmann HK (ed.): Guidelines in Health Care. Baden-Baden, Nomos-Verlagsgesellschaft, 1998, pp 162–193.
Article / Publication Details
Published online: November 17, 2004
Issue release date: June 1999
Number of Print Pages: 10
Number of Figures: 3
Number of Tables: 2
ISSN: 1663-2818 (Print)
eISSN: 1663-2826 (Online)
For additional information: https://www.karger.com/HRP
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
PubMed ID
